[1] Khalifa A, Lewin D N, Sasso R, et al. The utility of liver biopsy in the evaluation of liver disease and abnormal liver function tests[J].Am J Clin pathol, 2021, 156 (2): 259-267.
[2] Shi R, Yang F, Wu H, et al. The diagnostic value of liver biopsy for unexplained liver dysfunction: a retrospective study[J].J Multidiscip Healthc, 2024, 17: 2399-2407.
[3] 梁文霞, 孔银, 丁洁, 等. 不明原因的慢性血生化异常患者病因诊断及其肝组织学表现:一项单中心横断面回顾性研究[J].实用肝脏病杂志, 2023, 26 (4): 492-495.
[4] 杨永峰. 药物性肝损伤病理学的特征及鉴别诊断[J].临床肝胆病杂志, 2021, 37 (11): 2530-2533.
[5] Kleiner D E. Histopathological challenges in suspected drug-induced liver injury[J].Liver Int, 2018, 38 (2): 198-209.
[6] Gasmi B, Kleiner D E. Liver histology: diagnostic and prognostic features[J].Clin Liver Dis, 2020, 24 (1): 61-74.
[7] Lv T, Yu H, Han X, et al. Histopathological features predicting long-term clinical outcomes in patients with vanishing bile duct syndrome[J].Clin Transl Hepatol, 2023, 11 (5): 1161-1169.
[8] Apel K, Pütz K, Tolkach Y, et al. Drug-induced liver injury-significance of pathology[J]. Pathologe, 2020, 41 (5): 457-470.
[9] 秦婷婷. 304例药物性肝损伤患者临床分型与病理分型的相关分析[D]. 吉林大学, 2022.
[10] Han S K, Baik S K, Kim M Y. Non-alcoholic fatty liver disease: definition and subtypes[J].Clin Mol Hepatol, 2023, 29 (suppl): S5-S16.
[11] 田爱平, 杨永峰. 非酒精性脂肪性肝病诊断——病理的重要性[J].临床肝胆病杂志, 2023, 39 (3): 491-497.
[12] Kusano H, Kondo R, Ogasawara S, et al. Utility of sonic hedgehog and keratin 8/18 immunohistochemistry for detecting ballooned hepatocytes[J].Histopathology, 2022, 80 (6): 974-981.
[13] 高静雯, 刘晓琳, 朱锦舟, 等. 非酒精性脂肪性肝病的病理改变及相关分子机制[J].肝脏, 2022, 27 (2): 144-147.
[14] Yin X, Guo X, Liu Z, et al. Advances in the diagnosis and treatment of non-alcoholic fatty liver disease[J].Int J Mol Sci, 2023, 24 (3): 2844.
[15] Newsome P N, Sasso M, Deeks J J, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study[J].Lancet Gastroenterol Hepatol, 2020, 5 (4): 362-373.
[16] Theurer S, Kälsch J, Schwertheim S, et al. Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease[J].Pathologe, 2020, 41 (5): 434-443.
[17] Brunt E M, Kleiner D E, Carpenter D H, et al. NAFLD: reporting histologic findings in clinical practice[J].Hepatology, 2021, 73 (5): 2028-2038.
[18] Myoteri D, Sakellariou S, Tiniakos D G. Histopathology of autoimmune hepatitis: an update[J]. Adv Anat Pathol, 2025, 32(6):414-426.
[19] Covelli C, Sacchi D, Sarcognato S, et al. Pathology of autoimmune hepatitis[J].Pathologica, 2021, 113 (3): 185-193.
[20] Ueda K, Aizawa Y, Kinoshita C, et al. Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: a cohort study[J].Medicine (Baltimore), 2022, 101 (29): e29484.
[21] 金伯旬, 张丽, 娜仁图雅, 等. 急性表现与非急性表现的自身免疫性肝炎患者临床和肝组织病理学特征分析[J].实用肝脏病杂志, 2024, 27 (3): 366-369.
[22] 杨文君. 自身免疫性肝炎的病理学诊断[J]. 临床肝胆病杂志, 2024, 40 (6): 1082-1087.
[23] You H, Ma X, Efe C, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis[J].Hepatol Int, 2022, 16 (1): 1-23.
[24] 王秋鹏, 甘梅富. 原发性胆汁性胆管炎的病理学诊断[J].临床肝胆病杂志, 2024, 40 (6): 1088-1092.
[25] Sarcognato S, Sacchi D, Grillo F, et al. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis[J].Pathologica, 2021, 113 (3): 170-184.
[26] Ellez H I, Danis N, Akarca U S. Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis[J].Acta Gastroenterol Belg, 2024, 87 (2): 282-286.
[27] Shah S K, Bowlus C L. Autoimmune markers in primary biliary cholangitis[J].Clin Liver Dis, 2024, 28 (1): 93-101.
[28] Franceschini T, Vasuri F, Muratori P, et al. A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center[J].Virchows Arch, 2021, 479 (5): 937-945.
[29] Herta T, Schröder M, Geisel D, et al. Management of IgG4-related cholangitis: diagnosis, therapy, and long-term surveillance[J].Gastroenterol Rep (Oxf), 2025, 13: goaf032.
[30] 杨秋霞, 侯灼, 周秋烨, 等. IgG4相关性自身免疫性肝炎的临床和病理特征分析[J].肝脏, 2024, 29 (4): 444-447.
[31] 熊清芳, 杨永峰. 遗传代谢性肝病的组织病理学特征和诊断思路[J]. 中华肝脏病杂志, 2018, 26 (12): 885-888. |
